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Introduction 
According to the CDC’s National Center for Health Statistics, 
more than one-third (36.5%) of U.S adults are obese. It is the 
main risk factor for type-2-diabetes, hypertension, 
dyslipidemia and atherosclerosis. Nutraceuticals such as 
Xanthohumol have shown potential to inhibit adipogeneis, 
however, their bioavailability has remained controversial. 
Hence there is a need to develop targeted therapy which will 
increase the concentration of Xanthohumol on adipose 
tissues. Currently, magnetic drug delivery has been used to 
develop targeted therapies where conventional therapies have 
proven to be less effective. Among various types of 
nanoparticles ultrasmall superparamagnetic iron oxide 
nanoparticles (USPIO) have found considerable attention in 
magnetic drug delivery as they are easy to synthesize, inert, 
and are biocompatible. 
The synthesized USPIO-amine would be conjugated to XN via 
HOOC-PEG-COOH linker. The general reaction for the 
development of XN loaded superparamagnetic iron oxide 
nanoparticle is shown in scheme 1. The presence of USPIO, 
USPIO-amine, and USPIO-PEG was confirmed by FTIR and the 





We have successfully loaded PEG on to the iron oxide 
nanoparticles. Presence of stretching and bending vibrational 
bands in the region of 2700 – 3000 cm-1 and 900-1300 cm-1 , 
respectively, confirm the presence of amine and PEG on the 
USPIO nanoparticle. The evaluation of Xanthohumol onto the 
surface of iron oxide nanoparticle is being characterized and 
via FTIR. The percentage loading on XN on nanoparticles will 
be quantified via HPLC.  These XN loaded nanoparticles can 
be directed to any sites on the body under the influence of 
external magnetic field. This will improve the bioavailability of 
Xanthohumol as well as reduce systemic toxicity if any.   
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The presence of amine functional groups on the surface of 
USPIO was quantified using ninhydrin Assay. The ninhydrin 
assay revealed that 1 mg of amine functionalized UPSIO 
had 22mg of amine groups. Xanthohumol was then 
conjugated to the surface of amine-USPIO using via a 
polyethylene glycol linker. The presence of amine and PEG 
on the surface of nanoparticles was confirmed via IR (Fig 2). 
The amount of Xanthohumol tagged onto the surface of 
nanoparticles will be quantified using HPLC. The particle 
size of the synthesized nanoparticles was evaluated using 
TEM. TEM confirm the presence of spherical morphology 
with average particle size of 20-25nm  and the toxicity and 
therapeutic potency of Xanthohumol tagged to USPIO will 
be evaluated in vitro.  
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Scheme 1: Synthetic Scheme for the development of XN loaded 
nanoparticles. 
Figure 3: TEM images confirm the presence of 
USPIO (Fe3O4 and Fe3O4 amine nanoparticles with 
spherical morphology and particle size in the range 
of 20-25nm.  
Development of XN Loaded Iron Oxide nanoparticles 
Figure 2: Presence of stretching and bending vibrational bands in the region of 2700 – 
3000 cm-1 and 900-1300 cm-1 , respectively, confirm the presence of amine and PEG on 
the USPIO nanoparticle. 
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